Paul Thomas

Filings by Paul Thomas span 3 companies, the busiest being Axogen, Inc., Abiomed Inc and Surgalign Holdings, Inc. The record holds 15 filings, for trades running from 7 May 2021 to 19 June 2026.

Sales make up the whole of the open-market record (3 sales, €1.1M). Outside the open market, there are 8 share grants and 3 option exercises.

The record was last updated on 23 June 2026 with an option exercise in Axogen, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.